Cerus Endovascular Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 6

Cerus Endovascular General Information

Description

Developer of proprietary interventional neuroradiology devices designed to support the treatment of neurovascular diseases. The company's neuroradiology devices are used for the treatment of hemorrhagic strokes and a range of aneurysm morphologies, including unruptured wide-necked bifurcation and bifurcation aneurysms, enabling the interventional neuroradiologists to treat minimally invasive neurovascular diseases, particularly intracranial aneurysms.

Contact Information

Website
www.cerusendo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 47757 Fremont Boulevard
  • Fremont, CA 94538
  • United States
+1 (510) 000-0000

Cerus Endovascular Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerus Endovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Jul-2021 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 21-Feb-2020 000.00 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 21-Jul-2016 00.000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 30-Jun-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC $3M Completed Generating Revenue
1. Early Stage VC (Series A) 03-May-2013 $3M $3M 00.000 Completed Generating Revenue
To view Cerus Endovascular’s complete valuation and funding history, request access »

Cerus Endovascular Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 000.0 000.0 00 000.0 0.00
Ordinary 33,789 $0.000065 $77.35 $77.35 1x $77.35 5.45%
Series A 140,388 $0.000065 $19.53 $19.53 1x $19.53 22.66%
To view Cerus Endovascular’s complete cap table history, request access »

Cerus Endovascular Patents

  • 37

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Cerus Endovascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210259719-A1 Clot removal distal protection methods Pending 20-Feb-2020 000000000
JP-2020531152-A Blocking device Pending 21-Aug-2017 000000000000
EP-3672499-A1 Occlusion device Pending 21-Aug-2017 000000000000
CA-3073232-A1 Occlusion device Pending 21-Aug-2017 000000000000
US-20210153871-A1 Occlusion device Pending 21-Aug-2017 A61B17/12113
To view Cerus Endovascular’s complete patent history, request access »

Cerus Endovascular Executive Team (5)

Name Title Board Seat Contact Info
Stephen Griffin Ph.D Board Member, Director & President
David Jennings Chief Financial Officer & Company Secretary
Lori Adels Ph.D Chief Compliance Officer
Sam Milstein Ph.D Chairman & Director
You’re viewing 4 of 5 executive team members. Get the full list »

Cerus Endovascular Board Members (6)

Name Representing Role Since
Franklin Berger Cerus Endovascular Board Member 000 0000
John Kilcoyne Self Board Member 000 0000
Paul Brooke Self Board Member 000 0000
Sam Milstein Ph.D Cerus Endovascular Chairman & Director 000 0000
Stephen Griffin Ph.D Cerus Endovascular Board Member, Director & President 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Cerus Endovascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerus Endovascular Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andover Ventures Venture Capital Minority 000 0000 000000 0
Johnston Associates Venture Capital Minority 000 0000 000000 0
Mid Atlantic Bio Angels Angel Group Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
John Oates Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial